The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Open accessAbstract
BACKGROUND: A new pandemic influenza A (H1N1) virus has emerged, causing illness globally, primarily in younger age groups. To assess the level of preexisting immunity in humans and to evaluate seasonal vaccine strategies, we measured the antibody response to the pandemic virus resulting from previous influenza infection or vaccination in different age groups. METHODS: Using a microneutralization assay, we measured cross-reactive antibodies to pandemic H1N1 virus (2009 H1N1) in stored serum samples from persons who either donated blood or were vaccinated with recent seasonal or 1976 swine influenza vaccines. RESULTS: A total of 4 of 107 persons (4%) who were born after 1980 had preexisting cross-reactive antibody titers of 40 or more against 2009 H1N1, whereas 39 of 115 persons (34%) born before 1950 had titers of 80 or more. Vaccination with seasonal trivalent inactivated influenza vaccines resulted in an increase in the level of cross-reactive antibody to 2009 H1N1 by a factor of four or more in none of 55 children between the ages of 6 months and 9 years, in 12 to 22% of 231 adults between the ages of 18 and 64 years, and in 5% or less of 113 adults 60 years of age or older. Seasonal vaccines that were formulated with adjuvant did not further enhance cross-reactive antibody responses. Vaccination with the A/New Jersey/1976 swine influenza vaccine substantially boosted cross-reactive antibodies to 2009 H1N1 in adults. CONCLUSIONS: Vaccination with recent seasonal nonadjuvanted or adjuvanted influenza vaccines induced little or no cross-reactive antibody response to 2009 H1N1 in any age group. Persons under the age of 30 years had little evidence of cross-reactive antibodies to the pandemic virus. However, a proportion of older adults had preexisting cross-reactive antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903810 · Cited by 3,037
Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E., Deyde, V., et al. (2009) · Science · doi:10.1126/science.1176225 · Cited by 2,499
Self-citationIn vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y., Tamura, D., Sakai-Tagawa, Y., Noda, T., et al. (2009) · Nature · doi:10.1038/nature08260 · Cited by 1,073
Rowe, T., Abernathy, R. A., Hu-Primmer, J., Thompson, W. W., Lu, X., Lim, W., Fukuda, K., Cox, N. J., & Katz, J. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.937-943.1999 · Cited by 811
Self-citationTriple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009
Shinde, V., Bridges, C. B., Uyeki, T. M., Shu, B., Balish, A., Xu, X., Lindstrom, S., Gubareva, L. V., Deyde, V., Garten, R. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903812 · Cited by 607
Katz, J. D., Hancock, K., Veguilla, V., Zhong, W., Lü, X., Sun, H., Butler, E. N., Dong, L., Liu, F., Li, Z. N., et al. (2009) · MMWR Morbidity and Mortality Weekly Report · Cited by 521
Self-citationDETERMINANTS OF IMMUNITY TO INFLUENZA INFECTION IN MAN
POTTER, C. W., & OXFORD, J. S. (1979) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071545 · Cited by 452
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., et al. (2008) · Nature · doi:10.1038/nature07231 · Cited by 452
Self-citationDavenport, F. M., Hennessy, A. V., Francis, T., & Fabisch, W. T. T. A. O. P. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.98.6.641 · Cited by 399
Stephenson, I., Bugarini, R., Nicholson, K. G., Podda, A., Wood, J. M., Zambon, M. C., & Katz, J. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/428948 · Cited by 285
Self-citationMultiple Reassortment Events in the Evolutionary History of H1N1 Influenza A Virus Since 1918
Nelson, M. I., Viboud, C., Simonsen, L., Bennett, R. T., Griesemer, S. B., St. George, K., Taylor, J., Spiro, D. J., Sengamalay, N. A., Ghedin, E., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000012 · Cited by 280
INFLUENZAVIRUS INFECTIONS IN SEAVFLE FAMILIES, 1975–1979
FOX, J. P., HALL, C. E., COONEY, M. K., & FOY, H. M. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113407 · Cited by 261
Taubenberger, J. K., Reid, A. H., Janczewski, T. A., & Fanning, T. G. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2001.1020 · Cited by 210
Sasaki, S., Jaimes, M. C., Holmes, T. H., Dekker, C. L., Mahmood, K., Kemble, G. W., Arvin, A. M., & Greenberg, H. B. (2007) · Journal of Virology · doi:10.1128/jvi.01957-06 · Cited by 195
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus
Tumpey, T. M., García-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., & Basler, C. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308391100 · Cited by 175
Self-citationReflections on the 1976 swine flu vaccination program
Sencer, D. J., & Millar, J. D. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051007 · Cited by 163
Shope, R. E. (1936) · Journal of Experimental Medicine · doi:10.1084/jem.63.5.669 · Cited by 158
Leroux‐Roels, I., Bernhard, R., Gerard, P. P., Dramé, M., Hanon, E., & Leroux-Roels, G. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001665 · Cited by 151
Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin
Newman, A. P., Reisdorf, E. S., Beinemann, J., Uyeki, T. M., Balish, A. L., Shu, B., Lindstrom, S., Achenbach, J. E., Smith, C., & Davis, J. P. (2008) · Emerging infectious diseases · doi:10.3201/eid1409.080305 · Cited by 115
Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1
Stephenson, I., Nicholson, K. G., Höschler, K., Zambon, M. C. F. A., Hancock, K., DeVos, J. R., Katz, J. M., Praus, M., & Banzhoff, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805274 · Cited by 99
Self-citationCorrelates of protection: Novel generations of influenza vaccines
Rimmelzwaan, G. F., & McElhaney, J. E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.043 · Cited by 79
Cited by
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
The human antibody response to influenza A virus infection and vaccination
Krammer, F. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 796
Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Miller, E., Hoschler, K., Hardelid, P., Stanford, E., Andrews, N., & Zambon, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62126-7 · Cited by 708
Metadata
- Authors
- Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., Brammer, T. L., Cox, N. J., Tumpey, T. M., & Katz, J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-11-12
- Volume
- 361
- Issue
- 20
- Pages
- 1945-1952
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068592034
- Cited by
- 1,259
- References
- 21
- FWCI
- 141.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.